» Articles » PMID: 33859622

D-Chiro-Inositol Regulates Insulin Signaling in Human Adipocytes

Overview
Specialty Endocrinology
Date 2021 Apr 16
PMID 33859622
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

D-Chiro-Inositol (D-Chiro-Ins) is a secondary messenger in the insulin signaling pathway. D-Chiro-Ins modulates insulin secretion, the mitochondrial respiratory chain, and glycogen storage. Due to these actions D-Chiro-Ins has been proposed to correct defective insulin function in a variety of conditions characterized by metabolic dysfunction, such as polycystic ovary syndrome (PCOS), obesity, gestational diabetes and fat accumulation at menopause. Since it is unclear whether D-Chiro-Ins directly acts on adipocytes, we aimed to study D-Chiro-Ins's actions on adipocyte viability, proliferation, differentiation, and insulin-related protein expression using a human adipocyte cell line derived from Simpson-Golabi-Behmel Syndrome (SGBS) which fully differentiates to mature adipocytes. Throughout differentiation, cells were treated with D-Chiro-Ins, 17β-estradiol (E2) or Insulin. Cell viability and proliferation were not affected by D-Chiro-Ins, then D-Chiro-Ins promoted cell differentiation only during the final days of the process, while E2 enhanced it from the first phases. D-Chiro-Ins stimulated lipid storage and the production of big lipid droplets, thus reducing the content of free fatty acids. We also found that D-Chiro-Ins, either alone or in combination with insulin and E2 increased the expression and activation of insulin receptor substrate-1 (IRS1) and glucose transporter type 4 (GLUT4). In conclusion, this work shows that D-Chiro-Ins plays a direct role in the differentiation and in the function of human adipocytes, where it synergizes with insulin and estrogen through the recruitment of signal transduction pathways involved in lipid and glucose storage. These findings give clear insights to better understand the actions of D-Chiro-Ins on fat metabolism in women in physiology and in a variety of diseases.

Citing Articles

<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).

Dinicola S, Unfer V, Soulage C, Yap-Garcia M, Bevilacqua A, Benvenga S Gynecol Obstet Invest. 2024; 89(4):284-294.

PMID: 38373412 PMC: 11309080. DOI: 10.1159/000536081.


Effectiveness of a Food Supplement Based on Glucomannan, D-Chiro-Inositol, Blume and Inulin in Patients with Metabolic Syndrome.

Citarrella R, Chianetta R, Amodeo S, Mirarchi L, Licata A, Soresi M Nutrients. 2024; 16(2).

PMID: 38257142 PMC: 10819678. DOI: 10.3390/nu16020249.


Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition.

Tortolini C, Gigli V, Rizzo F, Lenzi A, Bizzarri M, Angeloni A Sensors (Basel). 2023; 23(22).

PMID: 38005597 PMC: 10674735. DOI: 10.3390/s23229211.


Preventing Adipogenesis and Preserving Mitochondria and GLUT-4 Functions by Extracts and Isolated Compounds of Australian .

Asmara A, Chen H, Ung A Molecules. 2023; 28(18).

PMID: 37764453 PMC: 10535536. DOI: 10.3390/molecules28186677.


Diet Plus Inositols, α-Lactalbumin and : The Successful Combo to Restore Body Weight and Metabolic Profile in Obese and Dysmetabolic Patients.

Basciani S, Nordio M, Dinicola S, Unfer V, Gnessi L Nutrients. 2023; 15(14).

PMID: 37513560 PMC: 10385591. DOI: 10.3390/nu15143142.


References
1.
Ortmeyer H . Dietary myoinositol results in lower urine glucose and in lower postprandial plasma glucose in obese insulin resistant rhesus monkeys. Obes Res. 1996; 4(6):569-75. DOI: 10.1002/j.1550-8528.1996.tb00271.x. View

2.
Davis S, Lambrinoudaki I, Lumsden M, Mishra G, Pal L, Rees M . Menopause. Nat Rev Dis Primers. 2016; 1:15004. DOI: 10.1038/nrdp.2015.4. View

3.
Fischer-Posovszky P, Newell F, Wabitsch M, Tornqvist H . Human SGBS cells - a unique tool for studies of human fat cell biology. Obes Facts. 2010; 1(4):184-9. PMC: 6452113. DOI: 10.1159/000145784. View

4.
Milewska E, Czyzyk A, Meczekalski B, Genazzani A . Inositol and human reproduction. From cellular metabolism to clinical use. Gynecol Endocrinol. 2016; 32(9):690-695. DOI: 10.1080/09513590.2016.1188282. View

5.
Larner J, Brautigan D, Thorner M . D-chiro-inositol glycans in insulin signaling and insulin resistance. Mol Med. 2010; 16(11-12):543-52. PMC: 2972396. DOI: 10.2119/molmed.2010.00107. View